Journal of Interferon & Cytokine Research, 2025 Significant Associations Between Blood Cell Counts and a Large Number of Salivary Cytokines, Chemokines, and Growth Factors Eriksson L., Eriksson M., Gordh T. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySaliva | | | | |
Nature Communications, 2025 In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome Mizumaki H., Gao S., Wu Z. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Allergy, 2025 Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins Fehr D., Huynh‐Tran V., Maintz L. et al. Olink Target 96CVDDermatological DiseasesPathophysiologySerum | | | | |
Brain and Behavior, 2025 Causal Relationships Between the Gut Microbiota, Inflammatory Cytokines, and Amyotrophic Lateral Sclerosis: A Mendelian Randomization Analysis Changqing L., Leying Y., Caiyun M. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Discover Oncology, 2025 Exploring the causal relationship between immune factors and chondrosarcoma: a Mendelian randomization study Xu T., Xiao W., Li W. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
European Journal of Endocrinology, 2025 Proteomic variation underlies the heterogeneous risk of metabolic dysfunction-associated steatotic liver disease for subsequent chronic diseases Wu J., Wu G., Li J. et al. Olink Explore 3072/384HepatologyPathophysiologyPlasma | | | | |
Nature Communications, 2025 SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults’ responses Nehar-Belaid D., Mejías A., Xu Z. et al. Olink Target 96Infectious DiseasesPathophysiologySerum | | | | |
Scientific Reports, 2025 The contribution of oral infectious diseases in lacunar stroke based on meta-analysis and Mendelian randomization study Zheng Q., Xu T., Luo S. et al. Olink Target 96NeurologyInfectious DiseasesPathophysiologyPlasma | | | | |
Frontiers in Immunology, 2025 Investigation of potential protein biomarkers for the screening of placental-mediated fetal growth restriction disorders using targeted proteomics Olink technology Zhou X., Wang W., Chen L. et al. Olink Explore 3072/384ObstetricsPatient StratificationPlasma | | | | |
Aging Cell, 2025 Quercetin Reduces Vascular Senescence and Inflammation in Symptomatic Male but Not Female Coronary Artery Disease Patients Mury P., Dagher O., Fortier A. et al. Olink Explore 3072/384CVDAgingPathophysiologyPlasma | | | | |
Journal of the American Heart Association, 2025 IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and Adhesion Lindkvist M., Göthlin Eremo A., Paramel G. et al. Olink Target 96CVDPathophysiologyCell Culture Supernatant | | | | |
Journal of the American Heart Association, 2025 Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention El‐Sabawi B., Tanriverdi K., Gajjar P. et al. Olink Explore 3072/384Metabolic DiseasesHepatologyPathophysiologyBlood | | | | |
Journal of the American Heart Association, 2025 Systemic Changes in Adults With a Fontan Circulation: Insights From the Plasma Proteome Kelly B., Ravndal M., Bach P. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
The Oncologist, 2025 First-in-human phase I open-label study of the anti–TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors Gutierrez M., Tang S., Powderly J. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
The Oncologist, 2025 First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors Powderly J., Gutierrez M., Balmanoukian A. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Nature, 2025 Interferon-γ orchestrates leptomeningeal anti-tumour response Remsik J., Tong X., Kunes R. et al. Olink Target 96OncologyPathophysiologyCSF | | | | |
Journal of Proteome Research, 2025 Dynamic Changes in Lymphocyte Subsets and Inflammation-Immune-Related Proteins in Patients with Thyroid Papillary Carcinoma before and after Radioactive Iodine Therapy Zhang J., Shi L., Zhang Z. et al. Olink Target 96OncologyPathophysiologyPatient StratificationPlasma | | | | |
Scientific Reports, 2025 Dissecting immune-mediated pathways in rheumatoid arthritis: A multivariate mediation analysis of antibodies and circulating proteins Niu J., Zhang P., Liu W. et al. Olink Target 96Immunological & Inflammatory DiseasesCross-platform ValidationPlasma | | | | |
BMC Neurology, 2025 CD28+ CD45RA− CD8br AC mediated the effects of Interleukin- 6 on Alzheimer's disease: A Mendelian Randomization Study Xu R., Gao Y. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Journal for ImmunoTherapy of Cancer, 2025 Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control Maldonado M., Gracia-Hernandez M., Le L. et al. Olink Target 48 MouseOncologyImmunotherapyPathophysiologyMouse Tissue Lysate | | | | |